Brokerages Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Target Price at $30.57
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has been assigned an average recommendation of “Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has been assigned an average recommendation of “Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month […]
